assignment

4 trials

Sponsors

Fujimoto Masafumi, Shoji Yoshihisa, Tahara Nobuhiro

Conditions

Mild Cognitive Impermeant :MCI and Mild Dementia includes Alzheimer's dementia Mild Cognitive ImpermeantPatients scheduled for elective surgery under general anesthesiaPatients with type 2 diabetes and a glycated hemoglobin level of 7% or more type 2 diabetesSubjects with pathologically diagnosed transthyretin amyloidosis excluded from insurance cover transthyretin amyloidosis

Phase 2

Effects of supplement McB on cognitive function in Patients with Mild Cognitive Impairment and mild dementia

RecruitingJPRN-jRCTs071200050

Shoji YoshihisaMild Cognitive Impermeant :MCI and Mild Dementia includes Alzheimer's dementia Mild Cognitive Impermeant

Start: 2021-10-28Target: 70Updated: 2026-06-29

Phase 3

Effects of glavonoid for transthyretin amyloidosis

RecruitingJPRN-jRCTs071230091

Tahara NobuhiroSubjects with pathologically diagnosed transthyretin amyloidosis excluded from insurance cover transthyretin amyloidosis

Start: 2024-01-11Target: 40Updated: 2026-06-29

Unknown Phase

The Influence of Oral Semaglutide for Vascular Inflammation in Japanese Patients with Type 2 Diabetes

RecruitingJPRN-jRCTs071220027

Tahara NobuhiroPatients with type 2 diabetes and a glycated hemoglobin level of 7% or more type 2 diabetes

Start: 2023-02-17Target: 40Updated: 2026-06-29

The influence of remimazolam on the reversal of rocuronium-induced neuromuscular blockade with sugammadex

RecruitingJPRN-jRCT1071230073

Fujimoto MasafumiPatients scheduled for elective surgery under general anesthesia

Start: 2023-10-31Target: 30Updated: 2026-06-29

Related Papers

Comparison of reversal of rocuronium-induced neuromuscular blockade with sugammadex under remimazolam versus propofol anesthesia: a randomized clinical trial.

2025-05-26